{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:51:31Z","timestamp":1791165091378,"version":"4.1.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s6430","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T21:23:05Z","timestamp":1289424185000},"page":"657","source":"Crossref","is-referenced-by-count":86,"title":["Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease"],"prefix":"10.2147","author":[{"given":"Samuel","family":"Frank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,9]]},"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=7783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:10:40Z","timestamp":1477851040000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/tetrabenazine-the-first-approved-drug-for-the-treatment-of-chorea-in-u-peer-reviewed-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ndt.s6430","relation":{},"ISSN":["1176-6328"],"issn-type":[{"value":"1176-6328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}